Related Experiment Video
Updated: Aug 16, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta
1Department of Molecular Biology and Immunology, Institute for Cancer Research, University of North Texas Health Science Center, Fort Worth, TX 76107, USA. abasu@hsc.unt.edu
Abstract:
We have previously shown that protein kinase C (PKC) acts upstream of caspases to regulate cisplatin-induced apoptosis. Since extracellular signal-regulated kinases (ERKs) have also been implicated in DNA damage-induced apoptosis, we have examined if ERK signaling pathway acts downstream of PKC in the regulation of cisplatin-induced apoptosis. PKC activator PDBu induced ERK1/2 phosphorylation which was inhibited by general PKC inhibitor bisindolylmaleimide and Gö 6983 as well as the MEK inhibitor U0126 but not by the PKCdelta inhibitor rottlerin. Cisplatin caused a concentration-dependent activation of ERK1/2 in HeLa cells. The level of ERK2 was decreased in HeLa cells that acquired resistance to cisplatin (HeLa/CP). The MEK inhibitor U0126 inhibited cisplatin-induced ERK activation and attenuated cisplatin-induced cell death. Inhibition of PKCdelta by rottlerin or depletion of PKCdelta by siRNA inhibited cisplatin-induced ERK activation. These results suggest that cisplatin-induced DNA damage results in activation of ERK1/2 via PKCdelta.
Insights
Protein kinase C (PKC) and extracellular signal-regulated kinases (ERKs) regulate cisplatin-induced apoptosis. Cisplatin activates ERK1/2 via PKCdelta, suggesting a role in DNA damage response and chemoresistance.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Biochemistry
Background:
- Protein kinase C (PKC) regulates apoptosis.
- Extracellular signal-regulated kinases (ERKs) are involved in DNA damage response.
- The relationship between PKC, ERKs, and cisplatin-induced apoptosis requires further elucidation.
Purpose of the Study:
- To investigate the role of the ERK signaling pathway downstream of PKC in cisplatin-induced apoptosis.
- To determine the specific PKC isoform involved in this pathway.
- To explore the implications of this pathway in cisplatin-resistant cells.
Main Methods:
- Utilized PKC activators (PDBu) and inhibitors (bisindolylmaleimide, Gö 6983, rottlerin) to assess ERK1/2 phosphorylation.
- Employed MEK inhibitor U0126 to block ERK activation.
- Investigated cisplatin-induced apoptosis and ERK activation in HeLa and cisplatin-resistant HeLa/CP cells.
- Used siRNA to deplete PKCdelta and assess its effect on ERK activation.
Main Results:
- PKC activation by PDBu led to ERK1/2 phosphorylation, inhibited by general PKC inhibitors and U0126.
- Cisplatin induced concentration-dependent ERK1/2 activation in HeLa cells.
- ERK2 levels were reduced in cisplatin-resistant HeLa/CP cells.
- Inhibition of MEK (U0126) or PKCdelta (rottlerin, siRNA) suppressed cisplatin-induced ERK activation and cell death.
Conclusions:
- Cisplatin-induced DNA damage activates ERK1/2 signaling through PKCdelta.
- This PKCdelta-ERK pathway plays a crucial role in regulating cisplatin-induced apoptosis.
- Understanding this pathway may offer insights into overcoming cisplatin resistance.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
MAPK Signaling Cascades
Inhibition of Cdk Activity
Inhibition of CDK Activity
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.

